SCM Pharma Gets Aseptic Fill Project

UK-based contract manufacturing organisation SCM has secured a sterile filling and packaging project with Italian Molteni Therapeutics.

SCM Pharma, a  UK-based CMO, has secured a sterile filling and packaging project with Molteni Therapeutics, a specialty pharmaceutical company based in Italy, for a new drug substance in development for the topical treatment of infected skin lesions using the PhotoDynamic Therapy (PDT) approach.

SCM will provide product supply of an aseptically manufactured gel for a Phase II trial. This follows a successful initial collaboration for Phase I trials. The production process involves the thermal sterilization of a bulk solution before being mixed with the API and aseptically filled using isolator technology into small volume vials. The product is then labeled, randomized, packed and released to the clinical trial sites from the SCM’s MHRA-licensed facility.